![]() |
市場調査レポート
商品コード
1467830
血液バンク市場レポート:製品タイプ、バンクタイプ、機能、エンドユーザー、地域別、2024~2032年Blood Bank Market Report by Product Type, Bank Type, Function, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
血液バンク市場レポート:製品タイプ、バンクタイプ、機能、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界の血液バンク市場規模は2023年に172億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけて4.2%の成長率(CAGR)を示し、2032年までに251億米ドルに達すると予測しています。
血液バンクは、ドナーから血液を採取し、型別し、成分に分離し、保管し、患者への輸血に備える施設です。血液は赤血球(RBC)、血漿、血小板に分離され、必要性に応じてさまざまな人に輸血されます。血液バンクは、患者と血液製剤の適切な識別を行うことにより、輸血に関連する反応を回避します。さらに、病院、外来手術センター、製薬会社、研究センターなどに血液の流通サービスを提供しています。
血液や造血器官の障害に起因する希少遺伝性疾患、貧血、鎌状赤血球症などの血液疾患の有病率の増加は、市場を牽引する重要な要因の一つです。さらに、ヒト免疫不全ウイルス(HIV)やB型肝炎などの輸血感染症(TTI)の増加により、安全な血液の需要が増加しています。これは、世界の高齢者人口の増加とともに、市場の成長を促進しています。さらに、切断手術における赤血球(RBC)の需要も増加しています。このことは、入手が容易で保管や維持のコストが低いなど、赤血球(RBC)に関連する様々な利点と相まって、市場にプラスの影響を与えています。これに加えて、いくつかの国の政府は世界中で献血を促進するためのイニシアチブを取っています。これに伴い、拡大する医療産業は、エンドユーザーや投資家に有利な成長機会を提供しています。さらに、不十分なトレーニング方法、構造的異常、安全でない運動環境によるスポーツ中の事故件数の増加が、輸血中の充填赤血球(RBC)の需要を強化しています。
The global blood bank market size reached US$ 17.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.
A blood bank is a facility where blood is collected from donors, typed, separated into components, stored, and prepared for transfusion to patients. The blood is separated into red blood cells (RBCs), plasma, and platelets, which are transfused to different individuals according to their requirements. Blood banks avoid transfusion-related reactions by providing proper identification of the patients and blood products. In addition, they offer distribution services of blood to hospitals, ambulatory surgery centers, pharmaceutical companies, and research centers.
The growing prevalence of hematological diseases, such as rare genetic conditions, anemia, and sickle cell disease due to disorders of the blood and blood-forming organs, represents one of the key factors driving the market. Moreover, there is an increase in the demand for safe blood due to the rising cases of transfusion transmissible infections (TTI), such as human immunodeficiency viruses (HIV) and hepatitis B. This, along with the increasing geriatric population across the globe, is propelling the growth of the market. In addition, there is a rise in the demand for red blood cells (RBCs) in amputation surgeries. This, coupled with various benefits associated with red blood cells (RBCs), such as easy availability and low cost of storage and maintenance, is positively influencing the market. Besides this, governments of several countries are taking initiatives to promote blood donation around the world. In line with this, the expanding healthcare industry is offering lucrative growth opportunities to end-users and investors. Additionally, the rising number of accidents in sports due to poor training methods, structural abnormalities, and unsafe exercising environments is bolstering the demand for packed red blood cells (RBCs) during blood transfusions.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood bank market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, bank type, function, and end user.
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
Private
Public
Collection
Processing
Testing
Storage
Transportation
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics and Nursing Homes
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being American Association of Blood Banks, Blood Bank of Alaska, Canadian Blood Services, Haemonetics Corporation, Japanese Red Cross Society, New York Blood Center, NHS Blood and Transplant, Sanquin Bloedvoorziening, Terumo Corporation, The American National Red Cross and Vitalant.